Chronic myeloid leukemia: an overview of the determinants of effectiveness and therapeutic response in the first decade of treatment with imatinib mesylate in a Brazilian hospital

BACKGROUND: In the last decade, there has been a revolution in chronic myeloid leukemia treatment with the introduction of tyrosine kinase inhibitors with imatinib mesylate becoming the frontline therapy. OBJECTIVE: To evaluate the therapeutic efficacy of imatinib mesylate in treating chronic myeloi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cid, Danielle Maria Camelo, Magalhães, Silvia Maria Meira, Quixadá, Acy Telles de Souza, Honório, Rita Paiva Pereira, Costa, Paola Franssinetti Torres Ferreira, dos Reis, Samuel Roosevelt Campos, Carvalho, Selda Maria de Aguiar, Cid, David Antonio Camelo, Sucupira, Rafael Moura e, de Oliveira, Mariana Fátima Cabral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905819/
https://www.ncbi.nlm.nih.gov/pubmed/24478603
http://dx.doi.org/10.5581/1516-8484.20130120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905819/
https://www.ncbi.nlm.nih.gov/pubmed/24478603
http://dx.doi.org/10.5581/1516-8484.20130120

Ejemplares similares